These box office numbers do not include the cost of production or marketing costs. They also don't count the billions in merchandising that Disney has made over the last...Entertainmentread more
Stocks in Asia were set to trade lower on Monday, while investors await the launch of a Nasdaq-style technology board on the Shanghai Stock Exchange.Asia Marketsread more
Instagram began tests that hide "like" counts on posts. That means influencers who market products on Instagram will have to rely on different metrics to show success.Technologyread more
Peter Neupert worked for Microsoft and Amazon-backed Drugstore.com, where he got to know Jeff Bezos. He now advises start-ups.Technologyread more
Last week shows that oil prices are not the indicator for Middle East tensions they once were, and worries about global demand and growing U.S. production has changed that...Market Insiderread more
The firing of the tear gas was the latest confrontation between police and protesters who have taken to the streets for over a month to fight a proposed extradition bill and...China Politicsread more
Facebook Vice President David Marcus is the face of the company's Libra digital currency, but the original driving force was a 26-year-old female corporate-development...Technologyread more
Amazon's new policy for account suspensions doesn't go far enough to protect sellers from potentially unfair and wrongful suspensions, merchants say.Technologyread more
There is no end in sight to the Boeing 737 Max grounding after two fatal crashes, prompting airlines to rethink their growth plans.Airlinesread more
Gluskin Sheff's David Rosenberg is painting a painful picture for stocks as earnings season goes into full gear.Futures Nowread more
After a year of flooding, Midwest farmers face a stifling heat wave that's spreading across the U.S.Weather & Natural Disastersread more
The "Fast Money " traders said on Tuesday that mergers and acquisitions may keep pushing the biotechnology sector to new highs.
The iShares Nasdaq Biotechnology ETF (IBB) hit a high of $299 a share on Tuesday, its highest level since mid-January. The traders made their comments after Biogen shares jumped 9 percent Tuesday on a Wall Street Journal report of buyout interest from drug companies, including Merck and Allergan. A source later told CNBC that Allergan is unlikely to pursue the deal.
Trader Tim Seymour said that the Biogen deal "makes sense whether it happens or not."
He said, however, that M&A activity has been a part of the gains in the sector "for a long time." He explained that the industry saw less activity as it faced increased scrutiny from politicians and regulators.
"You've gotten to a place where moving the needle for some of these big biotech companies and big pharma is very, very difficult. There's no longer one big drug and therefore the pipelines need a lot more," Seymour said.
Trader Brian Kelly said that Tuesday's price action is "a big move for the size of the company." He stuck to his investment strategy of selling the biotech stocks on any strength because of the political risks heading into the general election. Kelly said, however, he wouldn't necessarily short the stocks.
Trader Guy Adami said that while the takeover interest is specific to Biogen, other companies in the sector look interesting. He said that Gilead Sciences has an "unbelievable balance sheet" and that the company could "make a move."
Tim Seymour is long APC, AVP, BAC, BBRY, CLF, DO, DVYE, EDC, EWZ, F, FB, FCX, FXI, GM, GOOGL, GRMN, GE, INTC, LQD, M, MCD, MPEL, NKE, RACE, RAI, RH, RL, SINA, T, TWTR, UA, VALE, VZ, XOM and short: SPY, XRT. His firm is long ABX, BABA, BIDU, CLF, EWZ, F, HD, KO, MCD, MPEL, NKE, PEP, PF, SAVE, SBUX, SINA, VALE, VIAB, WMT, WEN, YHOO, short HYG, IWM
Karen Finerman is long AAL, BAC, C, DAL, DRII, DRII calls, FB, FL, GOOG, GOOGL, JPM, LYV, KORS, KORS, KORS puts, M, MA, SEDG, SPY puts, UAL, URI, WIFI long call spreads. Her firm is long ANTM, AAPL, BAC, C, C calls, DRII, DRII calls, FB, GOOG, GOOGL, JPM, JPM calls, KORS, LYV, M, MOH, PLCE, SPY puts, URI, WIFI. Her firm is short IWM, MDY. Finerman is on the board of GrafTech International.
Brian Kelly is long Bitcoin, DXJ, GLD, SLV, US Dollar UUP. He is short the Swiss franc, euro and Japanese yen.
Guy Adami is long CELG, EXAS, GDX, INTC. Adami's wife, Linda Snow, works at Merck.